Silvia Nastasio

ORCID: 0000-0003-0200-5326
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Liver Diseases and Immunity
  • Pediatric Hepatobiliary Diseases and Treatments
  • Liver Disease Diagnosis and Treatment
  • Gallbladder and Bile Duct Disorders
  • Liver Disease and Transplantation
  • Celiac Disease Research and Management
  • Hepatitis B Virus Studies
  • Renal Diseases and Glomerulopathies
  • Diabetes and associated disorders
  • Pancreatitis Pathology and Treatment
  • Chronic Lymphocytic Leukemia Research
  • Immunodeficiency and Autoimmune Disorders
  • Biliary and Gastrointestinal Fistulas
  • Bone and Joint Diseases
  • Tattoo and Body Piercing Complications
  • Sarcoidosis and Beryllium Toxicity Research
  • IgG4-Related and Inflammatory Diseases
  • Congenital Anomalies and Fetal Surgery
  • Diet and metabolism studies
  • Bone health and treatments
  • Blood properties and coagulation
  • Abdominal vascular conditions and treatments
  • Pregnancy and Medication Impact
  • HIV/AIDS oral health manifestations
  • Microscopic Colitis

Boston Children's Hospital
2018-2024

Harvard University
2018-2024

Beth Israel Deaconess Medical Center
2023

University of Ferrara
2017-2018

Arcispedale Sant'Anna
2017-2018

University of Pisa
2011-2017

Azienda Ospedaliera Universitaria Pisana
2014-2016

Ospedale Santa Chiara
2013-2015

Shannon M. Vandriel Liting Li Huiyu She Jian‐She Wang Melissa A. Gilbert and 88 more Irena Jankowska Piotr Czubkowski Dorota Gliwicz‐Miedzińska Emmanuel Gonzalès Emmanuel Jacquemin Jérôme Bouligand Nancy B. Spinner Kathleen M. Loomes David A. Piccoli Lorenzo D’Antiga Emanuele Nicastro Étienne Sokal Tanguy Demaret Noelle H. Ebel Jeffrey A. Feinstein Rima Fawaz Silvia Nastasio Florence Lacaille Dominique Debray Henrik Arnell Björn Fischler Susan Siew Michael Stormon Saul J. Karpen René Romero Kyung Mo Kim Woo Yim Baek Winita Hardikar Sahana Shankar Amin J. Roberts Helen Evans M. Kyle Jensen Marianne Kavan Shikha S. Sundaram Alexander Chaidez Palaniswamy Karthikeyan María Camila Sanchez Maria Lorena Cavalieri Henkjan J. Verkade Way Seah Lee James E. Squires Christina Hajinicolaou Chatmanee Lertudomphonwanit Ryan T. Fischer Catherine Larson‐Nath Yael Mozer‐Glassberg Çiğdem Arıkan Henry C. Lin Jesús Quintero Seema Alam Déirdre Kelly Elisa de Carvalho Cristina Targa Ferreira Giuseppe Indolfi Rubén E. Quirós‐Tejeira Pinar Bulut Pier Luigi Calvo Zerrin Önal Pamela L. Valentino Dev M. Desai John Eshun Maria Rogalidou Antal Dezsöfi Sabina Więcek Gabriella Nebbia Raquel Borges Pinto Victorien M. Wolters María Legarda Tamara Andréanne N. Zizzo Jennifer García Kathleen B. Schwarz Marisa Beretta Thomas Damgaard Sandahl Carolina Jiménez‐Rivera Nanda Kerkar Jernej Brecelj Quais Mujawar Nathalie Rock Cristina Molera Busoms Wikrom Karnsakul Eberhard Lurz Ermelinda Santos Silva Niviann Blondet Luís Bujanda Uzma Shah Richard J. Thompson Bettina E. Hansen Binita M. Kamath

Background and Aims: Alagille syndrome (ALGS) is a multisystem disorder, characterized by cholestasis. Existing outcome data are largely derived from tertiary centers, real‐world lacking. This study aimed to elucidate the natural history of liver disease in contemporary, international cohort children with ALGS. Approach Results: was multicenter retrospective clinically and/or genetically confirmed ALGS diagnosis, born between January 1997 August 2019. Native survival (NLS) event‐free rates...

10.1002/hep.32761 article EN cc-by-nc Hepatology 2022-08-29
Bettina E. Hansen Shannon M. Vandriel Pamela Vig Will Garner Douglas Mogul and 90 more Kathleen M. Loomes David A. Piccoli Elizabeth B. Rand Irena Jankowska Piotr Czubkowski Dorota Gliwicz‐Miedzińska Emmanuel Gonzalès Emmanuel Jacquemin Jérôme Bouligand Lorenzo D’Antiga Emanuele Nicastro Henrik Arnell Björn Fischler Étienne Sokal Tanguy Demaret Susan Siew Michael Stormon Saul J. Karpen René Romero Noelle H. Ebel Jeffrey A. Feinstein Amin J. Roberts Helen Evans Shikha S. Sundaram Alexander Chaidez Winita Hardikar Sahana Shankar Ryan T. Fischer Florence Lacaille Dominique Debray Henry C. Lin M. Kyle Jensen Catalina Jaramillo Palaniswamy Karthikeyan Giuseppe Indolfi Henkjan J. Verkade Catherine Larson‐Nath Rubén E. Quirós‐Tejeira Pamela L. Valentino Maria Rogalidou Antal Dezsöfi James E. Squires Kathleen B. Schwarz Pier Luigi Calvo Jesús Quintero Andréanne N. Zizzo Gabriella Nebbia Pinar Bulut Ermelinda Santos Silva Rima Fawaz Silvia Nastasio Wikrom Karnsakul María Legarda Tamara Cristina Molera Busoms Déirdre Kelly Thomas Damgaard Sandahl Carolina Jiménez‐Rivera Jesús M. Bañales Quais Mujawar Liting Li Huiyu She Jian‐She Wang Kyung Mo Kim Seak Hee Oh María Camila Sanchez Maria Lorena Cavalieri Way Seah Lee Christina Hajinicolaou Chatmanee Lertudomphonwanit Orith Waisbourd‐Zinman Çiğdem Arıkan Seema Alam Elisa de Carvalho Melina U. Melere John Eshun Zerrin Önal Dev M. Desai Sabina Więcek Raquel Borges Pinto Victorien M. Wolters Jennifer García Marisa Beretta Nanda Kerkar Jernej Brecelj Nathalie Rock Eberhard Lurz Niviann Blondet Uzma Shah Richard J. Thompson Binita M. Kamath

Background and Aims: Alagille syndrome (ALGS) is characterized by chronic cholestasis with associated pruritus extrahepatic anomalies. Maralixibat, an ileal bile acid transporter inhibitor, approved pharmacologic therapy for cholestatic in ALGS. Since long-term placebo-controlled studies are not feasible or ethical children rare diseases, a novel approach was taken comparing 6-year outcomes from maralixibat trials aligned harmonized natural history cohort the G lobal AL agille A lliance...

10.1097/hep.0000000000000727 article EN cc-by-nc-nd Hepatology 2023-12-25

Celiac disease (CD) is common in patients with autoimmune liver (AILD); however, the long-term response to treatment of AILDs coexistent CD has not been explored detail. The aim present study was analyze features and immunosuppressive children hepatitis (AIH) associated CD.Retrospective prospective evaluation followed at a single center.Among 79 AIH, 15 (19%) had (9 type 1, 3 2, seronegative). In group AIH CD, female sex significantly more represented than alone; also, former group,...

10.1097/mpg.0b013e31828b1dfa article EN Journal of Pediatric Gastroenterology and Nutrition 2013-02-12

Abstract TE measures liver stiffness to assess fibrosis. Its use in post‐transplant patients was reported few small pediatric studies. We evaluated ability predict graft fibrosis a large cohort while comparing it the performance of APRI and FIB‐4. also investigated effect type on LSMs. Patients at Boston Children's Hospital who underwent LT LSM ≤ 1 year from biopsy (2007‐2018) were eligible. Ninety‐four (45%M) aged 1‐21 years (89% < 18 years; 13% 2 years) Median time between...

10.1111/petr.13736 article EN Pediatric Transplantation 2020-05-20

Piercing is the practice of puncturing some parts body, including area stomach, to apply ornamental objects. The presence oral and perioral piercings are a risk factor for numerous acute chronic complications, such as chipping dental enamel, lesions gums infection. in cavity may also act stimulant inflammation determine modifications components saliva. aim this study evaluate whether there variation inflammatory or immunitary saliva adult patients with labial tongue piercings. Twenty-five...

10.1177/1721727x1100900212 article EN European Journal of Inflammation 2011-05-01

To the Editor: We read with interest ESPGHAN Hepatology Committee Position Statement on Paediatric Autoimmune Liver Disease (1). were, however, surprised that giant cell hepatitis associated autoimmune haemolytic anaemia (GCH-AHA) was not included among paediatric liver conditions having a likely pathogenesis. GCH-AHA is rare disease of infancy unknown aetiology characterised by severe Coombs-positive anaemia. The current reasons to believe in an immune-mediated pathogenesis are (2) 1....

10.1097/mpg.0000000000001910 article EN Journal of Pediatric Gastroenterology and Nutrition 2018-02-01

Besides the transient bilirubin transport immaturity, preterm infants are particularly at risk for different forms and degrees of bile formation impairment because metabolic demands that not matched by functional maturation in first weeks life. Cholestasis, affecting approximately 1 2 500 infants, is more commonly reported with an incidence varying between 10 20%, it mainly due to a combination factors including delayed enteral nutrition, low birth weight, prolonged parenteral hypoxia,...

10.1186/1824-7288-40-s2-a12 article EN cc-by ˜The œItalian Journal of Pediatrics/Italian journal of pediatrics 2014-10-09
Coming Soon ...